# Amgen Inc. (AMGN) — Q3-2016 Earnings Results

**Report date:** 2016-10-27 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2016

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 0.99%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.02 | N/A | +8.09% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in the company's current trajectory while acknowledging market challenges. They reiterated their commitment to innovation and efficiency.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in R&D to drive future growth.

> There was an emphasis on maintaining operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report shows a solid performance with an EPS beat, which led to a slight increase in stock price by 0.99%. The positive surprise in EPS reflects the company's ability to manage costs effectively and perform well in its key markets. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2016_